Tamara Lotan Selected Research

trans-sodium crocetinate (crocetin)

4/2024	TFE3-Rearranged PEComa/PEComa-like Neoplasms: Report of 25 New Cases Expanding the Clinicopathologic Spectrum and Highlighting its Association With Prior Exposure to Chemotherapy.
12/2023	"Oncocytoid Renal Cell Carcinomas After Neuroblastoma" Represent TSC -mutated Eosinophilic Solid and Cystic Renal Cell Carcinomas : Association With Prior Childhood Malignancy and Multifocality With Therapeutic Implications.
11/2022	Xanthomatous Giant Cell Renal Cell Carcinoma: Another Morphologic Form of TSC -associated Renal Cell Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tamara Lotan Research Topics

Disease

15	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 12/2008
14	Neoplasms (Cancer) 04/2024 - 03/2008
5	Neoplasm Metastasis (Metastasis) 12/2023 - 04/2008
3	Renal Cell Carcinoma (Grawitz Tumor) 12/2023 - 02/2013
3	Adenocarcinoma 01/2023 - 09/2013
2	Melanoma (Melanoma, Malignant) 11/2022 - 02/2013
2	Ovarian Neoplasms (Ovarian Cancer) 12/2008 - 04/2008
1	Perivascular Epithelioid Cell Neoplasms 04/2024
1	Kidney Neoplasms (Kidney Cancer) 12/2023
1	Neuroblastoma 12/2023
1	Cysts 12/2023
1	Margins of Excision 01/2023
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 11/2022
1	Tuberous Sclerosis (Bourneville's Disease) 11/2022
1	Prostatic Intraepithelial Neoplasia 01/2021
1	Necrosis 01/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021
1	Paraganglioma (Paragangliomas) 02/2013
1	Granular Cell Tumor 02/2013
1	Alveolar Soft Part Sarcoma 02/2013
1	Carcinoma (Carcinomatosis) 02/2013
1	Hemorrhage 06/2008
1	Hematuria 08/2006

Drug/Important Bio-Agent (IBA)

4	AndrogensIBA 10/2023 - 06/2019
3	trans-sodium crocetinate (crocetin)IBA 04/2024 - 11/2022
3	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2022
2	Cathepsin KIBA 12/2023 - 02/2013
2	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2023
2	Keratin-20 (Cytokeratin 20)IBA 12/2023 - 11/2022
2	Glycoproteins (Glycoprotein)IBA 12/2023 - 11/2022
2	Androgen Receptors (Androgen Receptor)IBA 02/2023 - 12/2019
2	enzalutamideIBA 01/2023 - 06/2019
2	Phenobarbital (Luminal)FDA Link 01/2021 - 12/2019
2	Phosphotransferases (Kinase)IBA 12/2008 - 04/2008
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2008 - 04/2008
1	MTOR InhibitorsIBA 04/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Formaldehyde (Formol)FDA Link 12/2023
1	Docetaxel (Taxotere)FDA Link 12/2023
1	ParaffinIBA 12/2023
1	abirateroneIBA 02/2023
1	Hormones (Hormone)IBA 02/2023
1	InterferonsIBA 02/2023
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2023
1	IgA receptor (protein B)IBA 11/2022
1	TOR Serine-Threonine KinasesIBA 11/2022
1	CollagenIBA 01/2022
1	GP 4 (GP4)IBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020
1	TensinsIBA 01/2020
1	Androgen Receptor AntagonistsIBA 06/2019
1	Protein Isoforms (Isoforms)IBA 03/2015
1	Keratins (Keratin)IBA 03/2015
1	MAP Kinase Kinase 4IBA 02/2012
1	Protein Kinases (Protein Kinase)IBA 12/2008
1	Mitogen-Activated Protein KinasesIBA 12/2008
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 04/2008
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 03/2008

Therapy/Procedure

10	Therapeutics 12/2023 - 06/2019
4	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 11/2011
3	Castration 12/2023 - 01/2022
3	Radiotherapy 02/2023 - 06/2019
2	Nephrectomy 06/2008 - 08/2006
1	Drug Therapy (Chemotherapy) 04/2024
1	Salvage Therapy 01/2023